SCHEMBL28419302

SCHEMBL28419302

NC(=O)C(S)n1ccnn1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.37
FOLH1 Q04609 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20514206 0.83 CYP19A1 (0.41) CYP19A1FOLH1
SCHEMBL12503737 0.75 CYP19A1 (0.37) CYP19A1FOLH1
SCHEMBL3752518 0.73 NOS1 (0.36)
SCHEMBL2754373 0.71 LMNA (0.38) CYP19A1FOLH1
SCHEMBL4555556 0.71 CYP19A1 (0.34) CYP19A1FOLH1
SCHEMBL20397456 0.69
SCHEMBL4554894 0.68 FOLH1 (0.45) CYP19A1FOLH1
SCHEMBL10510353 0.68
SCHEMBL17825837 0.67 CYP19A1 (0.59) CYP19A1
SCHEMBL4377410 0.67 CYP19A1 (0.41) CYP19A1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107001351-B Derivatives of 2- (1,2, 4-triazol-3-ylsulfanyl) -N-1,3, 4-thiadiazol-2-ylacetamide useful in the treatment of, in particular, diabetes 阿波格吕克斯有限公司 2020-06-05 CN disclosed